{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:18:05Z","timestamp":1792124285485,"version":"4.4.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Dr. Naohiko Kobayashi, Director of the Kobayashi Medical Clinic in Yasuzuka, Mibu","award":["#2023-9"],"award-info":[{"award-number":["#2023-9"]}]},{"name":"Dr. Naohiko Kobayashi, Director of the Kobayashi Medical Clinic in Yasuzuka, Mibu","award":["#2024-12"],"award-info":[{"award-number":["#2024-12"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute kidney injury (AKI) caused by red yeast rice Cholestehelp\u00ae (CP) tablets has become a public health issue in Japan. Puberulic acid (PA) contaminated in CP tablets may cause AKI; however, we detected silica nanoparticles in a CP patient. CP-related kidney injury was examined in rats that underwent left nephrectomy to increase silica nanoparticle loading.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Six male Sprague\u2013Dawley rats were administered CP and underwent left nephrectomy on day 4. Blood and urine samples were collected on day 11. Renal tissues were observed by electron microscopy and low-vacuum scanning electron microscopy-energy dispersive X-ray spectroscopy (LVSEM-EDS). The amount of PA in CP was measured, and PA was administered to normal rats and unilaterally nephrectomized rats.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Normal rats receiving CP (2KCP) had increased urine volume and lower urine specific gravity than controls, but no significant changes were observed in urinary protein, renal function, electrolytes, or blood gasses. Unilaterally nephrectomized rats receiving CP (1KCP) had increased water intake and urine volume, decreased urine specific gravity, and increased low-molecular-weight proteinuria. The glomeruli of 1KCP rats showed expanded subendothelial space and increased endocytic vesicles were observed in the proximal tubules relative to 2KCP rats. The accumulation of nanoparticles in the endosomes of the proximal tubules, and LVSEM-EDS detected silicon in renal tissue. Administration of PA at the doses in CP tablet did not result in significant renal injury.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Uninephrectomized rats administered CP tablets showed accumulation of silicon-containing nanoparticles in the proximal tubules and renal injury.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10157-025-02770-0","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T14:50:30Z","timestamp":1758552630000},"page":"15-24","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Red yeast rice supplement containing silica nanoparticles induces renal injury in rats with unilateral nephrectomy"],"prefix":"10.1007","volume":"30","author":[{"given":"Makoto","family":"Abe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Magome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Horibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadayuki","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9315-7546","authenticated-orcid":false,"given":"Akihiro","family":"Tojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"issue":"2","key":"2770_CR1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/ajcn\/69.2.231","volume":"69","author":"D Heber","year":"1999","unstructured":"Heber D, Yip I, Ashley JM, Elashoff DA, Elashoff RM, Go VLW. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am J Clin Nutr. 1999;69(2):231\u20136.","journal-title":"Am J Clin Nutr"},{"key":"2770_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/nu16101453","author":"E Trogkanis","year":"2024","unstructured":"Trogkanis E, Karalexi MA, Sergentanis TN, Kornarou E, Vassilakou T. Safety and efficacy of the consumption of the nutraceutical \u201cred yeast rice extract\u201d for the reduction of hypercholesterolemia in humans: a systematic review and meta-analysis. Nutrients. 2024. https:\/\/doi.org\/10.3390\/nu16101453.","journal-title":"Nutrients"},{"issue":"2","key":"2770_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ph18020200","volume":"18","author":"KH Cho","year":"2025","unstructured":"Cho KH, Bahuguna A, Kim JE, Lee SH, Lee Y, Jeon C. A comparative effect of 12-week dietary intervention of policosanol (Raydel\u00ae) and red yeast rice (RYR, Kobayashi) in managing dyslipidemia and organ damage in hyperlipidemic zebrafish. Pharmaceuticals. 2025;18(2):200. https:\/\/doi.org\/10.3390\/ph18020200.","journal-title":"Pharmaceuticals"},{"issue":"3","key":"2770_CR4","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.kint.2024.11.027","volume":"107","author":"M Shinzawa","year":"2025","unstructured":"Shinzawa M, Matsui I, Doi Y, Matsumoto A, Takahashi A, Nangaku M, et al. A nationwide questionnaire study evaluated kidney injury associated with Beni-koji tablets in Japan. Kidney Int. 2025;107(3):530\u201340. https:\/\/doi.org\/10.1016\/j.kint.2024.11.027.","journal-title":"Kidney Int"},{"issue":"1","key":"2770_CR5","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1186\/s12882-024-03903-5","volume":"25","author":"M Habuka","year":"2024","unstructured":"Habuka M, Hosojima M, Yata Y, Kurumada K, Yamagiwa M, Yonezawa M, et al. Fanconi syndrome with acute proximal tubular injury induced by a dietary supplement containing Beni-Koji: a case series report. BMC Nephrol. 2024;25(1):466. https:\/\/doi.org\/10.1186\/s12882-024-03903-5.","journal-title":"BMC Nephrol"},{"key":"2770_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-024-00946-3","author":"N Iwamura","year":"2024","unstructured":"Iwamura N, Tsutsumi K, Yamada S, Uesugi N, Hamashoji T, Arita Y, et al. Subclinical acute tubular necrosis potentially associated with red yeast rice consumption unexpectedly detected in a patient with membranous nephropathy. CEN Case Rep. 2024. https:\/\/doi.org\/10.1007\/s13730-024-00946-3.","journal-title":"CEN Case Rep"},{"key":"2770_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-024-00913-y","author":"Y Kawai","year":"2024","unstructured":"Kawai Y, Ozawa M, Isomura A, Mitsuhashi H, Yamaguchi S, Nagayama S, et al. A case of Fanconi syndrome that developed following a year of consumption of a red yeast rice supplement. CEN Case Rep. 2024. https:\/\/doi.org\/10.1007\/s13730-024-00913-y.","journal-title":"CEN Case Rep"},{"issue":"11","key":"2770_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfae318","volume":"17","author":"R Miyazaki","year":"2024","unstructured":"Miyazaki R, Takahashi Y, Katayama Y, Kawamura T, Tsuboi N, Yokoo T. Tubular glycogen accumulation in acute kidney injury associated with red yeast rice supplement. Clin Kidney J. 2024;17(11):sfae318. https:\/\/doi.org\/10.1093\/ckj\/sfae318.","journal-title":"Clin Kidney J"},{"issue":"6","key":"2770_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfae151","volume":"17","author":"R Miyazaki","year":"2024","unstructured":"Miyazaki R, Takahashi Y, Kawamura T, Ueda H, Tsuboi N, Yokoo T. Acute kidney tubular injury after ingestion of red yeast rice supplement. Clin Kidney J. 2024;17(6):sfae151. https:\/\/doi.org\/10.1093\/ckj\/sfae151.","journal-title":"Clin Kidney J"},{"issue":"9","key":"2770_CR10","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1016\/j.ekir.2024.06.022","volume":"9","author":"Y Murata","year":"2024","unstructured":"Murata Y, Hemmi S, Akiya Y, Miyasato K, Kobayashi H, Maruyama T, et al. Certain red yeast rice supplements in Japan cause acute tubulointerstitial injury. Kidney Int Rep. 2024;9(9):2824\u20138. https:\/\/doi.org\/10.1016\/j.ekir.2024.06.022.","journal-title":"Kidney Int Rep"},{"key":"2770_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-024-00903-0","author":"K Oda","year":"2024","unstructured":"Oda K, Murata T, Tanaka F, Oda H, Tsujimoto K, Fukumori A, et al. A case of acute kidney injury and Fanconi syndrome while taking multiple supplements, including Red Yeast Rice Cholesterol Help(\u00ae). CEN Case Rep. 2024. https:\/\/doi.org\/10.1007\/s13730-024-00903-0.","journal-title":"CEN Case Rep"},{"issue":"11","key":"2770_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2024.100908","volume":"6","author":"K Uchiyama","year":"2024","unstructured":"Uchiyama K, Otani M, Chigusa N, Sugita K, Matsuoka R, Hosoya K, et al. Acute kidney injury associated with red yeast rice (Beni-K\u014dji) supplement: a report of two cases. Kidney Med. 2024;6(11):100908. https:\/\/doi.org\/10.1016\/j.xkme.2024.100908.","journal-title":"Kidney Med"},{"issue":"1","key":"2770_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00795-024-00411-1","volume":"58","author":"M Abe","year":"2025","unstructured":"Abe M, Ogawa T, Magome N, Ono Y, Tojo A. Element analysis applied to investigate acute kidney injury induced by red yeast rice supplement. Med Mol Morphol. 2025;58(1):53\u201361. https:\/\/doi.org\/10.1007\/s00795-024-00411-1.","journal-title":"Med Mol Morphol"},{"key":"2770_CR14","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.4330-24","author":"T Doi","year":"2025","unstructured":"Doi T, Shimizu A, Morimoto E, Morii K, Okubo A, Mizuiri S, et al. A case of acute kidney injury and fanconi syndrome caused by a red yeast rice supplement. Internal Med. 2025. https:\/\/doi.org\/10.2169\/internalmedicine.4330-24.","journal-title":"Internal Med"},{"key":"2770_CR15","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.4908-24","author":"H Maruyama","year":"2025","unstructured":"Maruyama H, Sada KE, Oka M, Yanai M, Hidaka S, Kobayashi S. Successful resolution of suspected red yeast rice-induced nephropathy. Intern Med. 2025. https:\/\/doi.org\/10.2169\/internalmedicine.4908-24.","journal-title":"Intern Med"},{"issue":"3","key":"2770_CR16","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.ekir.2024.12.016","volume":"10","author":"M Shimokawa","year":"2025","unstructured":"Shimokawa M, Kajio Y, Kawanishi K, Kawanishi K, Shiomi M, Morikawa T, et al. Acute tubular injury and Fanconi syndrome associated with red yeast rice supplement. Kidney Int Rep. 2025;10(3):956\u20139. https:\/\/doi.org\/10.1016\/j.ekir.2024.12.016.","journal-title":"Kidney Int Rep"},{"issue":"1","key":"2770_CR17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ekir.2024.11.010","volume":"10","author":"S Ushimaru","year":"2025","unstructured":"Ushimaru S, Tominaga N. Acute kidney injury with Fanconi syndrome following intake of a red yeast rice supplement. Kidney Int Rep. 2025;10(1):269\u201370. https:\/\/doi.org\/10.1016\/j.ekir.2024.11.010.","journal-title":"Kidney Int Rep"},{"issue":"4","key":"2770_CR18","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1053\/j.ajkd.2024.08.007","volume":"85","author":"A Chikasue","year":"2025","unstructured":"Chikasue A, Taguchi K, Iwatani R, Kimura K, Okuda S, Uesugi N, et al. Three cases of red yeast rice-containing supplement-induced acute kidney injury and Fanconi syndrome. Am J Kidney Dis. 2025;85(4):522\u20136. https:\/\/doi.org\/10.1053\/j.ajkd.2024.08.007.","journal-title":"Am J Kidney Dis"},{"key":"2770_CR19","doi-asserted-by":"publisher","DOI":"10.1159\/000544795","author":"H Nakanoh","year":"2025","unstructured":"Nakanoh H, Tsuji K, Fukushima K, Haraguchi S, Kitamura S, Wada J. Supplement-induced acute kidney injury reproduced in kidney organoids. Am J Nephrol. 2025. https:\/\/doi.org\/10.1159\/000544795.","journal-title":"Am J Nephrol"},{"key":"2770_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-025-00984-5","author":"A Kamada","year":"2025","unstructured":"Kamada A, Hirose T, Hashimoto H, Konya Y, Sato F, Ishiyama K, et al. Tubular damage and SGLT2 expression in a patient with Beni-koji tablet-associated acute kidney injury and Fanconi syndrome. CEN Case Rep. 2025. https:\/\/doi.org\/10.1007\/s13730-025-00984-5.","journal-title":"CEN Case Rep"},{"issue":"4","key":"2770_CR21","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s11418-024-01827-w","volume":"78","author":"S Tanaka","year":"2024","unstructured":"Tanaka S, Masumoto N, Makino T, Matsushima Y, Morikawa T, Ito M. Novel compounds isolated from health food products containing beni-koji (red yeast rice) with adverse event reports. J Nat Med. 2024;78(4):845\u20138. https:\/\/doi.org\/10.1007\/s11418-024-01827-w.","journal-title":"J Nat Med"},{"issue":"1","key":"2770_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/toxins17010011","volume":"17","author":"HQ Pan","year":"2025","unstructured":"Pan HQ, Feng R, Tan YN, Qin XY, Cao YM, Mao XH, et al. Determination of puberulic acid in monascus-fermented red yeast rice by LC-MS\/MS combined with precolumn derivatization. Toxins. 2025;17(1):11. https:\/\/doi.org\/10.3390\/toxins17010011.","journal-title":"Toxins."},{"issue":"5","key":"2770_CR23","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/0002-9343(81)90374-0","volume":"71","author":"WK Bolton","year":"1981","unstructured":"Bolton WK, Suratt PM, Strugill BC. Rapidly progressive silicon nephropathy. Am J Med. 1981;71(5):823\u20138. https:\/\/doi.org\/10.1016\/0002-9343(81)90374-0.","journal-title":"Am J Med"},{"key":"2770_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/biom9100528","author":"AM Mahmoud","year":"2019","unstructured":"Mahmoud AM, Desouky EM, Hozayen WG, Bin-Jumah M, El-Nahass ES, Soliman HA, et al. Mesoporous silica nanoparticles trigger liver and kidney injury and fibrosis via altering TLR4\/NF-\u03baB, JAK2\/STAT3 and Nrf2\/HO-1 signaling in rats. Biomolecules. 2019. https:\/\/doi.org\/10.3390\/biom9100528.","journal-title":"Biomolecules"},{"key":"2770_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fmats.2023.1189463","volume":"10","author":"U Niroumand","year":"2023","unstructured":"Niroumand U, Firouzabadi N, Goshtasbi G, Hassani B, Ghasemiyeh P, Mohammadi-Samani S. The effect of size, morphology and surface properties of mesoporous silica nanoparticles on pharmacokinetic aspects and potential toxicity concerns. Front Mater. 2023;10:1189463. https:\/\/doi.org\/10.3389\/fmats.2023.1189463.","journal-title":"Front Mater"},{"issue":"6","key":"2770_CR26","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1248\/cpb.c21-00132","volume":"69","author":"R Saito","year":"2021","unstructured":"Saito R, Sennari G, Nakajima A, Kimishima A, Iwatsuki M, Ishiyama A, et al. Discoveries and syntheses of highly potent antimalarial troponoids. Chem Pharm Bull. 2021;69(6):564\u201372. https:\/\/doi.org\/10.1248\/cpb.c21-00132.","journal-title":"Chem Pharm Bull"},{"issue":"2","key":"2770_CR27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/ja.2010.124","volume":"64","author":"M Iwatsuki","year":"2011","unstructured":"Iwatsuki M, Takada S, Mori M, Ishiyama A, Namatame M, Nishihara-Tsukashima A, et al. In vitro and in vivo antimalarial activity of puberulic acid and its new analogs, viticolins A\u2013C, produced by sp FKI-4410. J Antibiot. 2011;64(2):183\u20138. https:\/\/doi.org\/10.1038\/ja.2010.124.","journal-title":"J Antibiot"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02770-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-025-02770-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02770-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T06:38:29Z","timestamp":1768545509000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-025-02770-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2770"],"URL":"https:\/\/doi.org\/10.1007\/s10157-025-02770-0","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,22]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest in association with the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All experiments, including animal experiments, received ethical approval from the Dokkyo Medical University Animal Experiment Committee and were conducted in compliance with the Dokkyo Medical University Animal Experiment Regulations (approval number: 1506).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}